ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AVCT Avacta Group Plc

45.00
-0.30 (-0.66%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta Group Plc LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.30 -0.66% 45.00 44.50 45.50 45.25 44.25 45.25 2,905,504 16:28:25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 10.06M -39.19M -0.1382 -3.26 127.63M
Avacta Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AVCT. The last closing price for Avacta was 45.30p. Over the last year, Avacta shares have traded in a share price range of 43.25p to 166.50p.

Avacta currently has 283,614,110 shares in issue. The market capitalisation of Avacta is £127.63 million. Avacta has a price to earnings ratio (PE ratio) of -3.26.

Avacta Share Discussion Threads

Showing 3276 to 3297 of 79775 messages
Chat Pages: Latest  143  142  141  140  139  138  137  136  135  134  133  132  Older
DateSubjectAuthorDiscuss
10/12/2018
08:06
Thought about buying back in but decided the mark up priced me out risk wise.
dave4545
10/12/2018
08:00
wow what a deal
dave4545
10/12/2018
07:56
"AVCT has a market capitalisation of just £26.2m which is way below the investment needed to get the company where it is today. Moreover, in the context of this deal, the current value represents an enormous opportunity that the market is totally overlooking. This deal looks set to be a wake-up call for the market."
1i1i1i
10/12/2018
07:55
Good luck to all holders (not me).....this might be the beginning providing Alistair doesn't use it as a step for another fundraising.
spekky
10/12/2018
07:55
30/32 pre market!
nobbygnome
10/12/2018
07:46
greater than six times the market cap from one deal gives people something to chew on and try to calculate fair value.

Possible cheeky bidder(s) might throw out an opportunistic offer

the drewster
10/12/2018
07:44
And out of the blue....
nobbygnome
10/12/2018
07:44
Hardman update out already (I haven't read it yet):
timbo003
10/12/2018
07:43
Surely this announcement is company changing because of the potential cash and validation of the approach. Difficult to know what the valuation should be....but certainly above this level!
nobbygnome
10/12/2018
07:36
wan ... even though just "potential" I'd be amazed if this doesn't re-rate on this news
the drewster
10/12/2018
07:27
No cash upfront though.....but 'potential' for upfront payments.

So no WOW in my book, but it is a good validation.

wan
10/12/2018
07:21
Market cap was £27m as of Friday. 2019 turnover forecast was £3m. Suspect it will take some time for the market to work out the new fair price.
18bt
10/12/2018
07:13
$180m + $130m = $310m = potential worth. Stonking deal
gersemi
10/12/2018
07:10
Wow indeed😊
18bt
07/12/2018
18:53
A few numpties posting today, always a good sign that good times are around the corner.
1i1i1i
07/12/2018
16:06
hxxps://simplywall.st/news/should-you-buy-avacta-group-plc-aimavct/

Under valued at 73p this will fly on good news. Really hope for a string of news soon.

danatkins
06/12/2018
12:22
Yes,I see Dr Smith is making more Jam Tomorrow statements.
Seems that any pending deals have now drifted out to 2019?
Let's face it Avacta simply can't get serious interest form the sector.
Let alone get any meaningful up front payments.
I am also very curious as to why we never get any feed back on the reaction to all of these major presentations Avacta are doing.
They always seem keen to announce these presentations....but then silence.
Worrying!

lantanatony
01/12/2018
08:27
High risk, potentially very high reward... Alistair really needs to gain some commercial traction and get recognition for all of the scientific validations.

It would only take one affimer based therapeutic and sentiment would shift massively.

the drewster
30/11/2018
21:52
Patience, all the ducks are being lined up.
1i1i1i
30/11/2018
21:29
Still no deals eh?
But meanwhile, the Management still remain in place along with their questionable Advisors

No wonder some people think Yorkshire is God's country!
At least it's affordable!

lantanatony
26/11/2018
12:23
Where are the deals?
lantanatony
08/11/2018
07:31
Unlikely ... this does look cautiously promising.
the drewster
Chat Pages: Latest  143  142  141  140  139  138  137  136  135  134  133  132  Older

Your Recent History

Delayed Upgrade Clock